Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Abstract IA07: Targeting micrometastasis for the treatment of ovarian cancer

Conference paper

Ahmed AA., (2018), Metabolic Changes in Ovarian Cancer

Targeting micrometastasis for the treatment of ovarian cancer.

Conference paper

Ahmed AA., (2018), CLINICAL CANCER RESEARCH, 24, 18 - 18

Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing

Journal article

Schuh A. et al, (2018), Molecular Case Studies, 4, a002279 - a002279

Tubal Ligation and Incidence of 26 Site-Specific Cancers in the Million Women Study

Other

Gaitskell K. et al, (2017), Obstetrical & Gynecological Survey, 72, 539 - 540

Engineering Synthetic Signaling Pathways with Programmable dCas9-Based Chimeric Receptors

Journal article

Baeumler TA. et al, (2017), Cell Reports, 20, 2639 - 2653

Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review

Journal article

Chen F. et al, (2017), BJOG: An International Journal of Obstetrics & Gynaecology, 124, 872 - 878

Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells

Journal article

Taylor C. et al, (2017), Oncotarget, 8

Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4

Journal article

Harjes U. et al, (2017), Oncogene, 36, 912 - 921

Expelling the “perpetrators”: ovarian cancer cells discard miR-6126 through exosomes to promote survival

Journal article

Masuda K. and Ahmed AA., (2017), Translational Cancer Research, 6, S5 - S7

How to make ovarian cancer cells “sick-too”

Journal article

Miranda F. and Ahmed AA., (2017), Cell Cycle, 16, 15 - 16

Load More